Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS von Chen, S., A, Bertolini, Koukou, G., Wendel, E.M., Thiels, C., Baumann, M., Lechner, C., Blaschek, A., Della Marina, A., Classen, G., Stüve, B., Kauffmann, B., Kapanci, T., Mayer, B., Otto, M., Rostásy, K.

Volltext

Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization von Wang, Haicui, Salter, Claire G, Refai, Osama, Hardy, Holly, Barwick, Katy E S, Akpulat, Ugur, Kvarnung, Malin, Chioza, Barry A, Harlalka, Gaurav, Taylan, Fulya, Sejersen, Thomas, Wright, Jane, Zimmerman, Holly H, Karakaya, Mert, Stüve, Burkhardt, Weis, Joachim, Schara, Ulrike, Russell, Mark A, Abdul-Rahman, Omar A, Chilton, John, Blakely, Randy D, Baple, Emma L, Cirak, Sebahattin, Crosby, Andrew H

Volltext

Untersuchungen über die Gogerichte in Westfalen und Niedersachsen von Johann Carl B. Stüve

Volltext bestellen

Wesen und Verfassung der landgemeinden und des ländlichen Grundbesitzes in Niederschsen und Westphalen von Johann Carl B. Stüve

Volltext bestellen

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study von Selmaj, Krzysztof, Prof, Li, David KB, Prof, Hartung, Hans-Peter, Prof, Hemmer, Bernhard, Prof, Kappos, Ludwig, Prof, Freedman, Mark S, Prof, Stüve, Olaf, MD, Rieckmann, Peter, Prof, Montalban, Xavier, Prof, Ziemssen, Tjalf, MD, Auberson, Lixin Zhang, MD, Pohlmann, Harald, MSc, Mercier, Francois, PhD, Dahlke, Frank, MD, Wallström, Erik, MD

Volltext

CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke von Stowe, Ann M, Wacker, Bradley K, Cravens, Petra D, Perfater, Jennifer L, Li, Min K, Hu, Ruilong, Freie, Angela B, Stüve, Olaf, Gidday, Jeffrey M

Volltext

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview von Rommer, P. S., Zettl, U. K., Kieseier, B., Hartung, H.‐P., Menge, T., Frohman, E., Greenberg, B. M., Hemmer, B., Stüve, O.

Volltext

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy von STÜVE, O, CRAVENS, P. D, MACMANUS, D, MILLER, D. H, RADÜ, E. W, CAMERON, E. M, MONSON, N. L, ZHANG, S, KIM, R, HEMMER, B, FROHMAN, E. M, PHILLIPS, J. T, REMINGTON, G. M, VON GELDERN, G, CEPOK, S, SINGH, M. P, COHEN TERVAERT, J. W, DE BAETS, M

Volltext

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study von Kappos, Ludwig, Li, David K. B, Stüve, Olaf, Hartung, Hans-Peter, Freedman, Mark S, Hemmer, Bernhard, Rieckmann, Peter, Montalban, Xavier, Ziemssen, Tjalf, Hunter, Brian, Arnould, Sophie, Wallström, Erik, Selmaj, Krzysztof

Volltext

Whole-Genome Patterns of Common DNA Variation in Three Human Populations von Hinds, David A., Stuve, Laura L., Nilsen, Geoffrey B., Halperin, Eran, Eskin, Eleazar, Ballinger, Dennis G., Frazer, Kelly A., Cox, David R.

Volltext

Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study von WAUBANT, E, PELLETIER, D, SCHWID, S, GOODMAN, A, KACHUCK, N, PREININGEROVA, J, WEINSTOCK-GUTTMAN, B, CALABRESI, P. A, MILLER, A, MOKHTARANI, M, IKLE, D, MURPHY, S, MASS, M, KOPETSKIE, H, DING, L, ROSENBERG, E, SPENCER, C, ZAMVIL, S. S, COHEN, J. A, KITA, M, CROSS, A, BAR, A, VOLLMER, T, RACKE, M, STIIVE, O

Volltext

Immune surveillance in multiple sclerosis patients treated with natalizumab von Stüve, Olaf, Marra, Christina M., Jerome, Keith R., Cook, Linda, Cravens, Petra D., Cepok, Sabine, Frohman, Elliot M., Phillips, J. Theodore, Arendt, Gabriele, Hemmer, Bernhard, Monson, Nancy L., Racke, Michael K.

Volltext

Multiple sclerosis therapy : An update on recently finished trials von KLEINSCHNITZ, Christoph, MEUTH, Sven G, STÜVE, Olaf, KIESEIER, Bernd, WIENDL, Heinz

Volltext

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity von Leussink, V. I., Lehmann, H. C., Meyer zu Hörste, G., Hartung, H.-P., Stüve, O., Kieseier, B. C.

Volltext

A sequence-based variation map of 8.27 million SNPs in inbred mouse strains von Montgomery, Julie, Beilharz, Erica J, Nilsen, Geoffrey B, Kang, Hyun Min, Eskin, Eleazar, Wade, Claire M, Cox, David R, Stuve, Laura L, Pethiyagoda, Charit L, Frazer, Kelly A, Bogue, Molly A, Johnson, Frank M, Daly, Mark J, Hinds, David A, Gupta, Robert V, Morenzoni, Matt M

Volltext

A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease von Lambracht-Washington, Doris, Qu, Bao-xi, Fu, Min, Anderson, Larry D, Eagar, Todd N, Stüve, Olaf, Rosenberg, Roger N

Volltext

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity von Stüve, Olaf, Youssef, Sawsan, Weber, Martin S, Nessler, Stefan, von Büdingen, Hans-Christian, Hemmer, Bernhard, Prod'homme, Thomas, Sobel, Raymond A, Steinman, Lawrence, Zamvil, Scott S

Volltext

Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations von Stuve, Olaf, Weideman, Rick A., McMahan, Danni M., Jacob, David A., Little, Bertis B.

Volltext

Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease von Stopschinski, Barbara E., Weideman, Rick A., McMahan, Danni, Jacob, David A., Little, Bertis B., Chiang, Hsueh-Sheng, Saez Calveras, Nil, Stuve, Olaf

Volltext

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis von Hemmer, Bernhard, Stüve, Olaf, Kieseier, Bernd, Schellekens, Huub, Hartung, Hans-Peter

Volltext